The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer

NARecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 22, 2023

Primary Completion Date

May 31, 2028

Study Completion Date

May 31, 2028

Conditions
Rectal Cancer
Interventions
RADIATION

Short Course Radiation Therapy (scRT)

Eligible patients will receive short course radiation therapy (scRT) of 25Gy over 5 days (fractions) for their localized rectal cancer. Research bloods stool and tissue will be collected at three time points: Baseline, end of radiation therapy and at surgery.

PROCEDURE

Total Mesenteric Excision (TME)

Subjects are expected to undergo total mesenteric Excision(TME) even if subjects have achieved complete response by imaging.TME is a specific surgical technique used in the treatment of rectal cancer in which the bowel with the tumor is entirely removed along with surrounding fat and lymph nodes.

Trial Locations (5)

10065

RECRUITING

New York Presbyterian Brooklyn Methodist Hospital, Brooklyn

RECRUITING

Weill Cornell Medical College, New York

11355

NOT_YET_RECRUITING

New York Presbyterian Hospital - Queens, New York

60637

RECRUITING

The University of Chicago, Chicago

08901

RECRUITING

Rutgers Cancer Institute of New Jersey, New Brunswick

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Weill Medical College of Cornell University

OTHER